MP62-02 RACIAL DISPARITIES IN MAGNETIC RESONANCE IMAGING-GUIDED BIOPSY FOR THE DIAGNOSIS OF PROSTATE CANCER IN THE UNITED STATES

Abstract

You have accessJournal of UrologyProstate Cancer: Localized: Active Surveillance II (MP62)1 Sep 2021MP62-02 RACIAL DISPARITIES IN MAGNETIC RESONANCE IMAGING-GUIDED BIOPSY FOR THE DIAGNOSIS OF PROSTATE CANCER IN THE UNITED STATES Peter Hanna, Arveen Kalapara, Bradly Watarai, Stephanie Jarosek, Badrinath Konety, and Christopher Warlick Peter HannaPeter Hanna More articles by this author , Arveen KalaparaArveen Kalapara More articles by this author , Bradly WataraiBradly Watarai More articles by this author , Stephanie JarosekStephanie Jarosek More articles by this author , Badrinath KonetyBadrinath Konety More articles by this author , and Christopher WarlickChristopher Warlick More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000002102.02AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: Multiparametric magnetic resonance imaging (MRI) has evolved into an invaluable diagnostic tool for localized prostate cancer. Racial disparities exist between Black and White American patients in treatment access and outcomes. We assessed the discrepancies in receiving MRI prior to biopsy in prostate cancer patients based on their racial disparities in the United States. METHODS: A retrospective review of a de-identified commercial health insurance claims database in the United States (OptumLabs® Data Warehouse) to identify men who underwent prostate biopsy and MRI between 2010 and 2017. Prostate biopsy was considered the index event and our cohort was restricted to men with continuous enrolment of 12 months prior and 1 month following biopsy. Race was classified as Black, White, Asian, or Hispanic. Our primary outcome was the utilization of MRI prior to prostate biopsy. RESULTS: We identified 108,557 patients who underwent prostate biopsy, including 86,997 White, 12,051 Black, 7220 Hispanic, and 2289 Asian men. Median age was 64 years (IQR, 58-70). Overall, 176 of 19674 (0.9%) men underwent MRI prior to biopsy in 2010, compared with 2590 of 13106 (19.8%) (table 1) in 2017 (p<0.001). On multivariable logistic regression, Black men were significantly less likely to receive MRI within 6 months prior to prostate biopsy than White men (OR 0.89, 95% CI 0.81-0.99). Hispanic men (OR 1.65, 1.50-1.81) and Asian men (OR 1.68, 1.43-1.97) were significantly more likely to receive MRI than White men. CONCLUSIONS: Among commercially insured men in the United States, Black men are significantly less likely to receive prostate MRI prior to biopsy compared to White, Hispanic, and Asian cohorts. Further studies are required to validate these findings and to identify reasons for these trends. Source of Funding: None © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 206Issue Supplement 3September 2021Page: e1092-e1093 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Peter Hanna More articles by this author Arveen Kalapara More articles by this author Bradly Watarai More articles by this author Stephanie Jarosek More articles by this author Badrinath Konety More articles by this author Christopher Warlick More articles by this author Expand All Advertisement Loading ...